tert-Butyl 3-azabicyclo[3.1.0]hexan-1-ylcarbamate → 6-(1-Amino-3-azabicyclo[3.1.0]hexan-3-yl)-N-(4-(chlorodifluoromethoxy)phenyl)-5-(1H-pyrazol-5-yl)nicotinamide
Reaktionsgleichung
Cl[C:2]1[C:21]([C:22]2[N:26](C3CCCCO3)[N:25]=[CH:24][CH:23]=2)=[CH:20][C:5]([C:6]([NH:8][C:9]2[CH:14]=[CH:13][C:12]([O:15][C:16]([Cl:19])([F:18])[F:17])=[CH:11][CH:10]=2)=[O:7])=[CH:4][N:3]=1.[C:33]12([NH:39]C(=O)OC(C)(C)C)[CH2:38][CH:37]1[CH2:36][NH:35][CH2:34]2>>[NH2:39][C:33]12[CH2:38][CH:37]1[CH2:36][N:35]([C:2]1[C:21]([C:22]3[NH:26][N:25]=[CH:24][CH:23]=3)=[CH:20][C:5]([C:6]([NH:8][C:9]3[CH:10]=[CH:11][C:12]([O:15][C:16]([Cl:19])([F:18])[F:17])=[CH:13][CH:14]=3)=[O:7])=[CH:4][N:3]=1)[CH2:34]2Komponenten
3
Edukt 2
Produkt 1
Versuchsvorschrift
The title compound was prepared in an analogous fashion to that described in Example 33 using 6-chloro-N-(4-(chlorodifluoromethoxy)phenyl)-5-(1-(tetrahydro-2H-pyran-2-yl)-1H-pyrazol-5-yl)nicotinamide (Stage 48.2) and tert-butyl 3-azabicyclo[3.1.0]hexan-1-ylcarbamate to afford an off-white foam. HPLC (Condition 4) tR=4.32 min, UPLC-MS (Condition 3) tR=0.79 min, m/z=461.1 [M+H]+.